Piper Jaffray Analyst Says Alexion Set for Gains; Stock Slides
July 15, 2013 at 15:43 PM EDT
In a report released Monday afternoon, Piper Jaffray analyst Ian Somaiya got bullish on Alexion Pharma (NASDAQ: ALXN ), adding to his Overweight rating, saying that its a takeout target. In the report, Somaiya bumped his price target on the firm up to $138 from $124, while saying the company
